GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » Cyclically Adjusted Revenue per Share

Asensus Surgical (FRA:2TX) Cyclically Adjusted Revenue per Share : €0.39 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Asensus Surgical's adjusted revenue per share for the three months ended in Mar. 2024 was €0.004. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.39 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Asensus Surgical's average Cyclically Adjusted Revenue Growth Rate was -69.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -51.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -32.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Asensus Surgical was 11.30% per year. The lowest was -51.20% per year. And the median was -9.50% per year.

As of today (2024-05-21), Asensus Surgical's current stock price is €0.234. Asensus Surgical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €0.39. Asensus Surgical's Cyclically Adjusted PS Ratio of today is 0.60.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Asensus Surgical was 17.56. The lowest was 0.08. And the median was 1.43.


Asensus Surgical Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Asensus Surgical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical Cyclically Adjusted Revenue per Share Chart

Asensus Surgical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.53 2.70 2.76 1.66 0.41

Asensus Surgical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 0.42 0.40 0.41 0.39

Competitive Comparison of Asensus Surgical's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Asensus Surgical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asensus Surgical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's Cyclically Adjusted PS Ratio falls into.



Asensus Surgical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Asensus Surgical's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.004/131.7762*131.7762
=0.004

Current CPI (Mar. 2024) = 131.7762.

Asensus Surgical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.018 100.560 0.024
201409 0.010 100.428 0.013
201412 0.022 99.070 0.029
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.148 101.861 0.191
201612 0.006 101.863 0.008
201703 0.194 102.862 0.249
201706 0.138 103.349 0.176
201709 0.013 104.136 0.016
201712 0.195 104.011 0.247
201803 0.251 105.290 0.314
201806 0.348 106.317 0.431
201809 0.289 106.507 0.358
201812 0.400 105.998 0.497
201903 0.116 107.251 0.143
201906 0.192 108.070 0.234
201909 0.104 108.329 0.127
201912 0.031 108.420 0.038
202003 0.019 108.902 0.023
202006 0.011 108.767 0.013
202009 0.007 109.815 0.008
202012 0.009 109.897 0.011
202103 0.009 111.754 0.011
202106 0.004 114.631 0.005
202109 0.009 115.734 0.010
202112 0.009 117.630 0.010
202203 0.004 121.301 0.004
202206 0.004 125.017 0.004
202209 0.011 125.227 0.012
202212 0.010 125.222 0.011
202303 0.004 127.348 0.004
202306 0.004 128.729 0.004
202309 0.004 129.860 0.004
202312 0.019 129.419 0.019
202403 0.004 131.776 0.004

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Asensus Surgical  (FRA:2TX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Asensus Surgical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.234/0.39
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Asensus Surgical was 17.56. The lowest was 0.08. And the median was 1.43.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Asensus Surgical Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Asensus Surgical (FRA:2TX) Business Description

Traded in Other Exchanges
Address
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (FRA:2TX) Headlines

No Headlines